 |
Calling
all people with Type 2 diabetes and healthcare professionals |
| |
Diabetes UK would like you to fill in a quick
and easy online survey about hypoglycaemia or ‘hypos’(Diabetes UK) |
| |
|
|
Relationship
of baseline HBA1c and efficacy of glucose lowering therapies |
| |
A meta-analysis of randomised clinical trials
(NHS Evidence - Diabetes ) |
| |
|
|
Type
2 Diabetes Prevention: A Review |
| |
Recent clinical trials have convincingly shown
that lifestyle modification is the most effective tool in the prevention
or delay of type 2 diabetes (Clinical Diabetes) |
| |
|
|
Incorporating
Type 1 Diabetes Prevention Into Clinical Practice |
| |
Successful intervention efforts demand a thorough
understanding of disease pathogenesis and a refined approach to
disease prediction so that risks and benefits can be well balanced
(Clinical Diabetes) |
| |
|
|
Etiology
of Type 1 Diabetes |
| |
This review considers research in the field
of type 1 diabetes toward identifying disease mechanisms using
genetic approaches (Immunity) |
| |
|
|
Advances
in the Treatment of Diabetic Retinopathy |
| |
Diabetic retinopathy is the most common microvascular
complication of diabetes and remains one of the leading causes
of blindness worldwide among adults aged 20-74 years (Discovery
Medicine) |
| |
|
|
Comparative-Effectiveness
Study Confirms New Treatment for Diabetic Macular Edema |
| |
Researchers have shown that ranibizumab (Lucentis)
eye injections, often in combination with laser treatment, result
in better vision than laser treatment alone for diabetes-associated
swelling of the retina (NIH News) |
| |
|
|
IVGTT
glucose minimal model covariate selection by nonlinear mixed-effects
approach |
| |
In this work, the advantages of population techniques
are further explored by proposing integration of covariates in
the intravenous glucose tolerance test (IVGTT) glucose minimal
model analysis (American Journal of Physiology - Endocrinology
and Metabolism) |
| |
|
|
Victoza
is a "better diabetes drug" |
| |
Both high and low-dose injections of new diabetes
drug Victoza are more effective at reducing blood-sugar levels
than a daily dose of Januvia, researchers in the US have claimed
(Pharmacy Europe) |
| |
|
|
Phenomix
Announces Positive Results from a Phase 3 Study of Dutogliptin
in Type 2 Diabetes Mellitus |
| |
Dutogliptin is Phenomix' internally-discovered
dipeptidyl peptidase-4 (DPP-4) inhibitor (PharmaLive) |
| |
|
